1. Market Research
  2. > Theravance, Inc. - Product Pipeline Review - 2013

Theravance, Inc. - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 41 pages

Theravance, Inc. - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “Theravance, Inc. - Product Pipeline Review - 2013” provides data on the Theravance, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Theravance, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Theravance, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Theravance, Inc. - Brief Theravance, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Theravance, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Theravance, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Theravance, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Theravance, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Theravance, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Theravance, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Theravance, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Theravance, Inc. and identify potential opportunities in those areas.

Table Of Contents

Theravance, Inc. - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Theravance, Inc. Snapshot 5
Theravance, Inc. Overview 5
Key Information 5
Key Facts 5
Theravance, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Theravance, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Theravance, Inc. - Pipeline Products Glance 11
Theravance, Inc. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Theravance, Inc. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Theravance, Inc. - Drug Profiles 15
Compound-39b 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
TD-1211 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
TD-1607 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
TD-1792 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
TD-2872 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
TD-4208 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
TD-8954 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
TD-9855 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
telavancin hydrochloride 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
THRX-198321 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
THRX-200495 25
Product Description 25
Mechanism of Action 25
RandD Progress 25
velusetrag 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
Theravance, Inc. - Pipeline Analysis 27
Theravance, Inc. - Pipeline Products by Therapeutic Class 27
Theravance, Inc. - Pipeline Products By Target 29
Theravance, Inc. - Pipeline Products by Route of Administration 30
Theravance, Inc. - Pipeline Products By Mechanism of Action 31
Theravance, Inc. - Recent Pipeline Updates 33
Theravance, Inc. - Dormant Projects 37
Theravance, Inc. - Discontinued Pipeline Products 38
Discontinued Pipeline Product Profiles 38
TD-6301 38
Theravance, Inc. - Locations And Subsidiaries 39
Head Office 39
Appendix 40
Methodology 40
Coverage 40
Secondary Research 40
Primary Research 40
Expert Panel Validation 40
Contact Us 41
Disclaimer 41

List of Tables

Theravance, Inc., Key Information 5
Theravance, Inc., Key Facts 5
Theravance, Inc. - Pipeline by Indication, 2013 8
Theravance, Inc. - Pipeline by Stage of Development, 2013 9
Theravance, Inc. - Monotherapy Products in Pipeline, 2013 10
Theravance, Inc. - Phase II, 2013 11
Theravance, Inc. - Phase I, 2013 12
Theravance, Inc. - Preclinical, 2013 13
Theravance, Inc. - Discovery, 2013 14
Theravance, Inc. - Pipeline By Therapeutic Class, 2013 28
Theravance, Inc. - Pipeline By Target, 2013 29
Theravance, Inc. - Pipeline By Route of Administration, 2013 30
Theravance, Inc. - Pipeline Products By Mechanism of Action, 2013 32
Theravance, Inc. - Recent Pipeline Updates, 2013 33
Theravance, Inc. - Dormant Developmental Projects,2013 37
Theravance, Inc. - Discontinued Pipeline Products, 2013 38

List of Figures

Theravance, Inc. - Pipeline by Indication, 2013 7
Theravance, Inc. - Pipeline by Stage of Development, 2013 9
Theravance, Inc. - Monotherapy Products in Pipeline, 2013 10
Theravance, Inc. - Pipeline By Therapeutic Class, 2013 27
Theravance, Inc. - Pipeline By Route of Administration, 2013 30
Theravance, Inc. - Pipeline Products By Mechanism of Action, 2013 31

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.